DIETHYLPROPION Drug Patent Profile
✉ Email this page to a colleague
When do Diethylpropion patents expire, and when can generic versions of Diethylpropion launch?
Diethylpropion is a drug marketed by Lannett Co Inc, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs. and is included in ten NDAs.
The generic ingredient in DIETHYLPROPION is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diethylpropion
A generic version of DIETHYLPROPION was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIETHYLPROPION?
- What are the global sales for DIETHYLPROPION?
- What is Average Wholesale Price for DIETHYLPROPION?
Summary for DIETHYLPROPION
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 10 |
| Drug Prices: | Drug price information for DIETHYLPROPION |
| DailyMed Link: | DIETHYLPROPION at DailyMed |
US Patents and Regulatory Information for DIETHYLPROPION
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091680-001 | Oct 24, 2011 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET;ORAL | 085916-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | DIETHYLPROPION HYDROCHLORIDE | diethylpropion hydrochloride | TABLET;ORAL | 088268-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
